IRIS UniCatt

Biolato, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.570
AS - Asia 2.534
EU - Europa 2.313
SA - Sud America 495
Continente sconosciuto - Info sul continente non disponibili 112
AF - Africa 61
OC - Oceania 7
Totale 9.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.467
SG - Singapore 1.151
DE - Germania 591
CN - Cina 576
IT - Italia 411
BR - Brasile 409
SE - Svezia 392
VN - Vietnam 254
FR - Francia 216
GB - Regno Unito 133
IE - Irlanda 125
UA - Ucraina 115
IN - India 89
FI - Finlandia 84
ID - Indonesia 83
JP - Giappone 75
RU - Federazione Russa 71
BD - Bangladesh 61
CA - Canada 57
HK - Hong Kong 57
TR - Turchia 41
AR - Argentina 32
PL - Polonia 29
BE - Belgio 27
KR - Corea 25
ZA - Sudafrica 24
IQ - Iraq 20
NL - Olanda 18
SA - Arabia Saudita 15
ES - Italia 14
AT - Austria 13
LT - Lituania 13
PK - Pakistan 12
MX - Messico 11
EC - Ecuador 10
CZ - Repubblica Ceca 9
VE - Venezuela 9
CL - Cile 8
CO - Colombia 8
IR - Iran 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
EG - Egitto 7
GR - Grecia 7
PE - Perù 7
PH - Filippine 7
RO - Romania 7
CI - Costa d'Avorio 6
DK - Danimarca 6
DZ - Algeria 6
JM - Giamaica 6
KE - Kenya 6
PY - Paraguay 6
TH - Thailandia 6
AU - Australia 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
BO - Bolivia 4
EU - Europa 4
JO - Giordania 4
KG - Kirghizistan 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
AL - Albania 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
LK - Sri Lanka 3
MD - Moldavia 3
PA - Panama 3
SV - El Salvador 3
TN - Tunisia 3
BB - Barbados 2
CG - Congo 2
CY - Cipro 2
HU - Ungheria 2
IS - Islanda 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NO - Norvegia 2
PR - Porto Rico 2
RE - Reunion 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HT - Haiti 1
KZ - Kazakistan 1
Totale 8.973
Salva come PNG Salva come JPEG
Città #
Singapore 631
San Jose 451
Ashburn 367
Chandler 322
New York 188
Dublin 124
Beijing 123
Dallas 102
Rome 97
Los Angeles 91
Ho Chi Minh City 85
Hefei 82
Lauterbourg 80
Milan 79
Jakarta 75
Tokyo 69
Jacksonville 65
Hanoi 58
Chicago 55
Frankfurt am Main 51
San Mateo 51
Nanjing 49
Munich 46
Wilmington 46
Helsinki 45
Boston 44
Hong Kong 43
Cattolica 41
Santa Clara 39
São Paulo 39
Dearborn 35
Moscow 35
The Dalles 35
Tukwila 34
Marseille 31
Princeton 28
Brussels 26
Seoul 25
Kent 24
London 23
Ann Arbor 22
Council Bluffs 22
Atlanta 21
Woodbridge 20
Boardman 19
Nürnberg 19
Buffalo 18
Houston 18
Nuremberg 17
Redwood City 17
Saint Petersburg 17
Seattle 17
Turku 17
Augusta 16
Denver 16
Paris 16
Izmir 15
Johannesburg 15
Montreal 15
Nanchang 15
Bremen 14
Brooklyn 14
Phoenix 14
Tianjin 14
Falls Church 13
Orem 13
Palermo 13
Toronto 12
Changsha 11
Da Nang 11
Dhaka 11
Rio de Janeiro 11
Shanghai 11
St Louis 11
Baghdad 10
Hebei 10
Kraków 10
Norwalk 10
Shenyang 10
Warsaw 10
Amsterdam 9
Bexley 9
Fairfield 9
Guangzhou 9
Haiphong 9
Istanbul 9
Las Vegas 9
Poplar 9
Stockholm 9
Falkenstein 8
Guarulhos 8
Kunming 8
Lawrence 8
Porto Alegre 8
Brasília 7
Düsseldorf 7
Goiânia 7
Lancaster 7
Mumbai 7
Naples 7
Totale 4.682
Salva come PNG Salva come JPEG
Nome #
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 300
A phase II study of sunitinib in advanced hepatocellular carcinoma 281
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 241
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 234
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 205
Liver transplantation in patients with alcoholic liver disease: A retrospective study 193
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 182
[The treatment of hepatocellular carcinoma: an update] 179
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 177
Vanishing-recurrent benign liver lesions 176
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 176
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 175
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 160
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 159
Severe giant cell arteritis associated with essential thrombocythaemia. 153
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 153
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 152
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 151
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 146
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 139
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 138
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 135
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 132
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 129
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 127
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 126
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 126
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 126
A giant calcified hepatic mass 124
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 124
Acute HEV hepatitis: clinical and laboratory diagnosis 123
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 122
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 120
Starvation hepatitis and refeeding-induced hepatitis: mechanism, diagnosis, and treatment 119
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 118
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 112
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines 110
Clinical impact of comorbidities in an Italian NAFLD cohort 109
Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study 108
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 107
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 106
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series 106
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 103
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 99
Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI 95
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 94
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 94
Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? 94
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 92
ORGANIZATIONAL AND ECONOMIC ISSUES RELATED TO THE INTRODUCTION OF BOCEPREVIR IN THE TREATMENT OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN ITALY 91
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy 91
Fatty liver and drugs: the two sides of the same coin 91
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach 91
Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 91
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review 83
Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI (BMC Gastroenterology, (2021), 21, 1, (317), 10.1186/s12876-021-01878-3) 83
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 82
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 81
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 80
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 80
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all 79
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 79
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 78
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 78
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 77
Upper limits of downstaging for hepatocellular carcinoma in liver transplantation 77
Liver transplantation for drug-induced acute liver failure 74
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 66
Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature 65
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 61
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 58
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 58
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 56
Abdominal angina 56
GAPO syndrome: a comprehensive examination and review of 105 clinical cases 54
Corrigendum to "Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at all" [J Hepatol 50 (2009) 1273-1277] (DOI:10.1016/j.jhep.2009.02.021) 33
Enhanced Liver Fibrosis Test, FIB-4 and FibroScan: Real-World Prognostic Accuracy for MASLD in a Biopsy-Controlled Cohort 17
Diagnostic accuracy and cost-effectiveness of the CAR-OLT score in predicting cardiac risk for liver transplantation 17
Liver Transplant Outcomes in Patients With Transjugular Intrahepatic Portosystemic Shunt: A Retrospective Cohort Study With Propensity Score Analysis 15
Totale 9.092
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022369 0 0 9 49 36 16 15 69 14 17 65 79
2022/20231.070 132 110 55 144 93 157 63 94 103 33 69 17
2023/2024708 48 171 26 46 34 109 45 33 13 40 47 96
2024/20251.415 31 29 125 55 107 54 42 61 204 131 310 266
2025/20263.680 567 111 270 412 536 273 621 169 283 215 137 86
2026/2027559 113 350 96 0 0 0 0 0 0 0 0 0
Totale 9.092